Cipla | CIPLA - Sales Revenues

Stock Price
1,332.70
Daily Change
6.00 0.45%
Monthly
-12.94%
Yearly
-9.43%
Q1 Forecast
1,299.11

Cipla reported INR75.18B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
aTyr Pharma USD 190K 2.03M Sep/2025
Cipla INR 75.18B 710M Dec/2025
Dr.Reddys Laboratories INR 87.27B 780M Dec/2025
Sun Pharmaceuticals INR 147.99B 3.21B Dec/2025
UPL INR 123.61B 3.42B Dec/2025